cme

Liver Masses

Dtsch Arztebl 2007; 104(33): A-2279

Spangenberg, H C; Thimme, R; Blum, H E

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Ros PR, Li KC: Benign liver tumors. Curr Probl Diagn Radiol 1989; 18: 125–55. MEDLINE
2. Ito K, Honjo K, Fujita T et al.: Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics 1996; 16: 273–93. MEDLINE
3. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr.: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. Jama 1979; 242: 644–8. MEDLINE
4. Wilkens L, Bredt M, Flemming P, Becker T, Klempnauer J, Kreipe HH: Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2001; 193: 476–82. MEDLINE
5. Bioulac-Sage P, Balabaud C, Wanless IR: Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 2001; 25: 1322–5. MEDLINE
6. Klatskin G: Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 1977; 73: 386–94. MEDLINE
7. Mettlin C, Natarajan N: Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surg Oncol 1981; 18: 73–85. MEDLINE
8. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194–200. MEDLINE
9. Devaney K, Goodman ZD, Ishak KG: Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078–91. MEDLINE
10. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127(5 Suppl 1): S5–16. MEDLINE
11. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218–24. MEDLINE
12. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM: Obesity and hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S97–103. MEDLINE
13. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460–8. MEDLINE
14. Malhi H, Gores GJ: Cholangiocarcinoma:modern advances in understanding a deadly old disease. J Hepatol 2006; 45: 856–67. MEDLINE
15. Spangenberg HC, Thimme R, Blum HE: Serum markers of hepatocelllar carcinoma. Semin Liver Dis 2006; 26: 385–90. MEDLINE
16. Lim JH, Park CK: Pathology of cholangiocarcinoma. Abdom Imaging 2004; 29: 540–7. MEDLINE
17. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney D, Ritts RE: Diagnostic role of serum CA 19-9in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993; 68: 874–879. MEDLINE
18. Boozari B, Lotz J, Galanski M, Gebel M: Diagnostic imaging of liver tumors. Current status. Internist 2007; 48: 8–20. MEDLINE
19. Bruix J, Sherman M, Llovet JM et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421–30. MEDLINE
20. Lang H, Broelsch CE: Liver resection and transplantation for hepatic tumors. Internist 2007; 48: 30–9. MEDLINE
21. Mohr L: Hepatocellular carcinoma. Therapeutic perspectives. Der Gastroenterologe 2007; 2: 34–9.
22. Spangenberg HC: Local ablative therapy. Der Gastroenterologe 2007; 2: 27–33.
23. Strey CW, Zapletal C, Bechstein WO: Surgical therapy of hepatocelllar carcinoma. Der Gastroenterologe 2007; 2: 19–6.
24. Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329–38. MEDLINE
25. Malek NP, Greten T, Kubicka S: Systemic tretament of liver and bilary tumors. Internist 2007; 48: 46–50. MEDLINE

Info

Specialities